Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: To explore the preliminary safety and efficacy of domestic single-port robot-assisted pyeloplasty in ureteropelvic junction obstruction.
Methods: Data from patients undergoing single-port robotic-assisted pyeloplasty (November 2023-May 2024) using the 'SHURUI' SP system through a single-site approach were reviewed. Details included patient demographics, intraoperative and postoperative data, and surgical outcomes.
Results: The study included 20 patients, ages 13-39, with a male-to-female ratio of 4:1.
Clinical Presentations: abdominal pain (7cases), infection (2cases), and asymptomatic (11cases). All surgeries were successful, with an average operation time of 147(IQR, 125-175) minutes, blood loss of 35(IQR, 30-60) mL, and a hospital stay of 5(IQR, 3-6)days. The ureteral stent was removed 6-8 weeks post-surgery, with a subsequent CT scan at 4 months showing 100% success based on pain and obstruction resolution.
Conclusion: The 'SHURUI' single-port robotic-assisted pyeloplasty is a safe and feasible treatment for UPJO in both adults and paediatric patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11884222 | PMC |
| http://dx.doi.org/10.1002/rcs.70056 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comment on: "Perioperative outcomes of the SHURUI single-port robotic system in urologic surgery: a systematic review and single-arm meta-analysis" by Li and Luo.
J Robot Surg
July 2025
Department of Urology, Lanzhou First People's Hospital, Lanzhou, 730030, China.
Perioperative outcomes of the SHURUI single-port robotic system in urologic surgery: a systematic review and single-arm meta-analysis.
J Robot Surg
June 2025
Department of Urology, Baoji People's Hospital, Baoji, 721000, People's Republic of China.
This study aims to systematically assess the perioperative safety, procedural feasibility, and early clinical efficacy of the SHURUI single-port robotic system in diverse urological operations by conducting a single-arm meta-analysis. An extensive literature search was performed using PubMed, Embase, and Web of Science databases to retrieve relevant studies involving SHURUI-assisted urologic surgeries, such as radical prostatectomy, partial nephrectomy, and pyeloplasty. Key perioperative indicators-operative duration, intraoperative blood loss, postoperative complications, length of hospitalization, and early functional outcomes-were extracted and synthesized using a random-effects model for pooled analysis.
View Article and Find Full Text PDFA novel single-port robotic system in urology: A prospective multicenter single-arm clinical trial evaluating feasibility and efficacy of first 50 cases.
Asian J Urol
April 2025
Department of Urology, The First Affiliated Hospital of Naval Medical University, Shanghai, China.
Objective: This study aimed to assess the feasibility and safety of the SHURUI single-port robotic surgical system for a range of major urological surgeries.
Methods: In this prospective, multicenter clinical trial, we examined the effectiveness of the SHURUI single-port robotic surgical system in urological interventions. The first 50 patients from four centers in China underwent single-port surgeries including partial nephrectomy, radical prostatectomy, partial adrenalectomy, and pyeloureteroplasty, exclusively by the SHURUI single-port robotic surgical system.
Safety and Feasibility of Novel Single-Port Robotic-Assisted Lobectomy/Segmentectomy for Lung Cancer.
Ann Thorac Surg
May 2025
Department of Thoracic Surgery, National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. Electronic address:
Background: Robotic-assisted thoracic surgery (RATS) has advanced lung cancer treatment with precise robotic arm maneuvers and 3-dimensional visualization. Whereas conventional RATS systems require multiple incisions, a uniportal approach is increasingly favored. However, current systems face challenges with maneuverability and incision size.
View Article and Find Full Text PDFPreliminary results of feasibility, safety and efficacy of robotic assisted laparoscopic pyeloplasty with the SHURUI single-port robotic surgical platform in children.
J Robot Surg
March 2025
Department of Pediatric Urology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, No. 56 Nan Li Shi Street, Beijing, 100045, China.
This study aims to evaluate the feasibility, safety and efficacy of robotic assisted laparoscopic pyeloplasty (RALP) with the novel SHURUI single-port (SR-SP) robotic surgical platform in children. Between November 2023 and April 2024, 20 pediatric patients diagnosed with ureteropelvic junction obstruction (UPJO) underwent transperitoneal RALP with the SR-SP surgical platform. Baseline characteristics, perioperative parameters and follow-up data were collected and analyzed.
View Article and Find Full Text PDF